Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
RSC Advances|March 22, 2024
Research progress of flexible pressure sensor based on MXene materialsZhigang Hu, Feihu Xie, Yangyang Yan, et al.Immunotargets and Therapy|January 30, 2025
PD(L)1 Inhibitors Plus Lenvatinib Vs Atezolizumab Plus Bevacizumab Combined With HAIC for Unresectable HCC: A Propensity Score Matching StudyZhaoqian He, Hua Chen, Chen Liang, et al.Frontiers in Oncology|October 18, 2019
The Clinicopathological and Prognostic Value of PD-L1 Expression in Cholangiocarcinoma: A Meta-AnalysisGang Xu, Lejia Sun, Yunzhu Li, et al.Biofabrication|June 30, 2020
Bioprinting of patient-derived in vitro intrahepatic cholangiocarcinoma tumor model: establishment, evaluation and anti-cancer drug testingShuangshuang Mao, Jianyu He, Yu Zhao, et al.Journal of Clinical Medicine|December 23, 2023
From Conversion to Resection for Unresectable Hepatocellular Carcinoma: A Review of the Latest StrategiesChen Liang, Zhaoqian He, Qiang Tao, et al.International Immunopharmacology|November 17, 2022
Immunotherapy combination with regorafenib for refractory hepatocellular carcinoma: A real-world studyXinyue Tu, Jing Yang, Yingbin Zheng, et al.Endocrine|May 14, 2020
Albumin binding function is a novel biomarker for early liver damage and disease progression in non-alcoholic fatty liver diseaseLejia Sun, Qing Wang, Meixi Liu, et al.Nanoscale Advances|September 22, 2022
Concave octopus-like PtCu nanoframe mediated photo-electro Fenton catalysis for fast organic dyestuff eliminationYangyang Yan, Shaowen Cheng, Ping Zhou, et al.Frontiers in Oncology|June 26, 2020
Application of a 3D Bioprinted Hepatocellular Carcinoma Cell Model in Antitumor Drug ResearchLejia Sun, Huayu Yang, Yanan Wang, et al.Biomaterials|October 2, 2020
Three-dimensional bio-printing of primary human hepatocellular carcinoma for personalized medicineFeihu Xie, Lejia Sun, Yuan Pang, et al.Pageof 1